“…Risks of unwanted treatment outcomes (death and lose-to-follow-up) were the same for both categories of patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: One hundred twenty-five non-anoxic patients with SE were retrospectively identified in two hospitals between 2008 and 2014 (39.2 % refractory SE). Patients’ treatment, demographic data, date of death, aetiology of SE, and the components of the STESS (age, history of seizures, level of consciousness and worst seizure type) were determined based on the patients’ records. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: From January 1, 2010, to December 31, 2014, 13 consecutive AS patients who were treated with osteotomy through the fracture gap were retrospectively reviewed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: All 745 participants recruited into the Renal Impairment In Secondary Care study to end March 2014 were included. Demographic, clinical and laboratory data were collected at baseline including an assessment of HRQL using the Euroqol EQ-5D-3L. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS/RESULTS: Between 2010–2014 at 47 hospitals participating in a statewide quality registry, 4.2% (n = 985) of 23,273 patients received a periprocedural blood transfusion. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: In 52 patients undergoing HCC resection between 2011 and 2014, liver and tumor tissue was collected during surgery. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…However, it is unclear whether the interaction between ghrelin and BMI is associated with a risk of all-cause and CV death in this population. METHODS: A prospective observational study was performed on 261 MHD outpatients (39% women, mean age 68.6 ± 13.6 years) recruited from October 2010 through April 2012, and were followed until November 2014 (median follow-up-28 months, interquartile range-19–34 months). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Anaemia is one of the major causes of death among children under five years in Africa, with a prevalence of 64.6% among pre-school children. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A retrospective review of our database of 562 patients with ILD between 2000 and 2014 identified 127 patients diagnosed with CTD-ILD. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A baseline clinical assessment was followed by investigator/owner contact every eight weeks from inclusion to death or end of study. Inclusion of dogs was conducted from November 2010 to September 2012, and the study terminated in June 2014. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: The Ontario Stroke Network (2011) list of stroke units and snowball sampling was used to identify all stroke units. During 2013 – 2014 an interviewer conducted telephone surveys with the stroke unit managers using closed and semi-open ended questions. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Ninety-six consecutive patients with locally advanced cervical carcinoma treated with radical chemoradiotherapy (CRT) in a single centre between 2011 and 2014 underwent 18F-FDG PET-CT approximately 3 months post-treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…All patients aged ≥65 years admitted to the ICU of Georges Pompidou Hospital (Paris, France) between 2009 and 2014 were eligible. RESULTS: Of 2327 eligible elderly patients (EP), 262 (75.0 ± 6.7 years) with solid tumors were analyzed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Eclampsia is one of the leading causes of maternal death worldwide. Maternal catastrophe is made worse in developing countries by the high incidence coupled with delayed presentation of patients and health facility constraints in effective management of eclampsia and its complications. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…From October 2009 to October 2014, 49 patients with AVN (stages I-III) were treated with core decompression at our institution. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Cancer is now becoming a leading cause of death. Chemotherapy is an important treatment for cancer patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We retrospectively studied CIN in renal allografts at our institution: its incidence, risk factors, and effect on long-term outcomes including allograft loss and death. METHODS: One hundred thirty-five renal transplant recipients undergoing 161 contrast-enhanced computed tomography (CT) scans or coronary angiograms (Cath) between years 2000 and 2014 were identified. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: During 2013 to 2014 all patients with type 2 diabetes in Sweden identified as new users of novel oral GLDs, either dipeptidyl peptidase‐4 (DPP‐4) inhibitors or sodium‐glucose cotransporter‐2 (SGLT2) inhibitors (only dapagliflozin available in Sweden during the study period), with those initiating insulin as a comparison group, in the Prescribed Drug Register were included and followed in the Patient and Cause of Death Registers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: We analysed unselected emergency admissions to four Oxford University National Health Service hospitals in the UK from Jan 1, 2006, to Dec 31, 2014. The primary outcome was death within 30 days of admission (in or out of hospital), analysed using Cox models measuring time from admission. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Date of registration: December 11, 2014. This study was registered at clinical trials after the beginning of recruitment of patients.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso